GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,773.50p
   
  • Change Today:
      12.50p
  • 52 Week High: 1,776.00p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 6,684,142
  • Market Cap: £73,510m
  • RiskGrade: 129

Newspaper Links

GSK raises profit forecast on the back of strong... 01-May-2024 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian
GlaxoSmithKline's mulled HIV spin-off 'bigger th... 23-Oct-2014 Telegraph
GlaxoSmithKline shares rise after drugs giant pl... 23-Oct-2014 Daily Mail
Glaxo to float its HIV cures as a standalone £15... 23-Oct-2014 The Independent
RBS chairman to head embattled GlaxoSmithKline 26-Sep-2014 Guardian
Royal Bank of Scotland chairman to move to Glaxo... 25-Sep-2014 Guardian
GSK to start production of Ebola vaccine as test... 29-Aug-2014 Guardian
MARKET REPORT: Evotec deal just the tonic for Gl... 28-Aug-2014 Express & Star
GlaxoSmithKline faces fresh drug bribery claims ... 13-Aug-2014 Guardian
Now GlaxoSmithKline faces claims of bribery from... 13-Aug-2014 Daily Mail
GlaxoSmithKline faces fresh bribery allegations ... 13-Aug-2014 The Independent
Peter Humphrey trial: GlaxoSmithKline to blame, ... 08-Aug-2014 Telegraph
GlaxoSmithKline looking to bag RBS chairman Sir ... 08-Aug-2014 Telegraph
Sir Philip Hampton may quit RBS in potential mov... 08-Aug-2014 Guardian
GlaxoSmithKline affirms policy of anti-corruptio... 24-Jul-2014 Guardian

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,773.50p
Change Today 12.50p
% Change 0.71 %
52 Week High 1,776.00p
52 Week Low 1,316.00p
Volume 6,684,142
Shares Issued 4,144.92m
Market Cap £73,510m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.66% above the market average20.66% above the market average20.66% above the market average20.66% above the market average20.66% above the market average
68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average
Price Trend
48.04% above the market average48.04% above the market average48.04% above the market average48.04% above the market average48.04% above the market average
67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average
Income
2.38% above the market average2.38% above the market average2.38% above the market average2.38% above the market average2.38% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 08-May-2024

Time Volume / Share Price
17:46 2,013 @ 1,773.37p
17:46 535,722 @ 1,773.37p
17:46 2,941 @ 1,773.37p
17:44 5,009 @ 1,773.50p
17:44 4,159 @ 1,773.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page